SR 33805
|
|
- CAS号:
- 121345-64-0
- 英文名:
- SR 33805
- 英文别名:
- SR 33805;2-(3,4-dimethoxyphenyl)ethyl](methyl)[3-(4-{[1-methyl-2-(propan-2-yl)-1H-indol-3-yl]sulfonyl}phenoxy)propyl]amine;Ca channels,channel,failing,Ca2+ channels,Ca2+,SR 33805,Calcium Channel,acute,L-type,SR-33805,Inhibitor,inhibit,depolarized,polarized,hearts,chronic,SR33805
- 中文名:
- SR 33805
- 中文别名:
- 化合物SR33805;3,4-二甲氧基-N-甲基-N-[3-[4-[[1-甲基-2-2-(1-甲基乙基))-1H-吲哚-‐3-基]磺酰基]苯氧基]丙基]苯乙胺
- CBNumber:
- CB01400869
- 分子式:
- C32H40N2O5S
- 分子量:
- 564.7354
- MOL File:
- 121345-64-0.mol
|
|
|
SR 33805化学性质
-
储存条件:
-
Store at -20°C
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to off-white
-
|
SR 33805性质、用途与生产工艺
SR33805 是一种有效的 Ca2+ 通道拮抗剂,在去极化和极化条件下的 EC50 值分别为 4.1 nM 和 33 nM。SR33805 阻止 L 型而不是 T 型 Ca2+ 通道。SR33805 可用于研究急性或慢性心脏衰竭。
L-type calcium channel
4.1 nM (EC
50
, in depolarized conditions)
|
L-type calcium channel
33 nM (EC
50
, in polarized conditions)
|
SR33805 (0.01-10 µM; 3 d) inhibits growth factor-induced proliferation of SMC (0.20
50<0.46 µM) in a dose-dependent manner.
SR33805 (10 µM; 10 min) restores the myocardial infarction (MI)-altered cell shortening without affecting the Ca
2+
transient amplitude.
SR33805 (10 µM) decreases the activity of recombinant PKA.
Cell Viability Assay
Cell Line:
|
Smooth muscle cells (SMC)
|
Concentration:
|
0.01, 0.1, 1, 10 µM
|
Incubation Time:
|
3 days
|
Result:
|
Inhibited in a dose-dependent manner FCS-, bFGF and PDGF-induced proliferation of porcine SMC with IC
50
s of 0.26±0.08, 0.46±0.1 and 0.20±0.04 µM, respectively.
|
SR33805 (20 mg/kg; a single i.p.) improves end-systolic strain and fractional shortening of MI hearts in rats.
SR33805 (5 mg/kg/day; p.o. for 38 d) significantly reduces intimal hyperplasia in pigs.
Animal Model:
|
Male Wistar rats (5 weeks) are subjected to coronary artery ligature
|
Dosage:
|
0.2, 2, 20 mg/kg
|
Administration:
|
A single i.p. injection
|
Result:
|
Increased significantly both end-systolic strain (ESS) and fractional shortening (FS) by about +38 and +26%, respectively at the dose of 20 mg/kg.
Did not affect other contractile parameters.
|
SR 33805
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | HY-136909 | SR33805 | | 1 mg | 685元 |
2024/08/19 | HY-136909 | SR 33805 SR33805 | 121345-64-0 | 5mg | 1800元 |
121345-64-0, SR 33805 相关搜索:
- 抑制剂
- 3,4-二甲氧基-N-甲基-N-[3-[4-[[1-甲基-2-2-(1-甲基乙基))-1H-吲哚-‐3-基]磺酰基]苯氧基]丙基]苯乙胺
- 化合物SR33805
- 121345-64-0
- 2-(3,4-dimethoxyphenyl)ethyl](methyl)[3-(4-{[1-methyl-2-(propan-2-yl)-1H-indol-3-yl]sulfonyl}phenoxy)propyl]amine
- Ca channels,channel,failing,Ca2+ channels,Ca2+,SR 33805,Calcium Channel,acute,L-type,SR-33805,Inhibitor,inhibit,depolarized,polarized,hearts,chronic,SR33805
- SR 33805